Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Salvysat is an herbal medicinal product developed by Johannes Bürger YS Lab, containing a dry extract of sage leaves (*Salvia officinalis*). It is primarily indicated for the treatment of excessive sweating (hyperhidrosis) and for use in oral hygiene, such as the relief of minor inflammations of the mouth and throat mucosa. The therapeutic effects are attributed to the complex mixture of constituents in sage, including tannins which provide astringent properties, and essential oils (such as thujone and cineole) and phenolic acids (such as rosmarinic acid) which exhibit antimicrobial and antiperspirant activities. Salvysat is available in oral film-coated tablet and liquid formulations, the latter of which can be used for both internal administration and local application as a rinse or gargle.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Salvysat.